Literature DB >> 16155572

Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins.

Eugenia Leikina1, Helene Delanoe-Ayari, Kamran Melikov, Myoung-Soon Cho, Andrew Chen, Alan J Waring, Wei Wang, Yongming Xie, Joseph A Loo, Robert I Lehrer, Leonid V Chernomordik.   

Abstract

Defensins are peptides that protect the host against microorganisms. Here we show that the theta-defensin retrocyclin 2 (RC2) inhibited influenza virus infection by blocking membrane fusion mediated by the viral hemagglutinin. RC2 was effective even after hemagglutinin attained a fusogenic conformation or had induced membrane hemifusion. RC2, a multivalent lectin, prevented hemagglutinin-mediated fusion by erecting a network of crosslinked and immobilized surface glycoproteins. RC2 also inhibited fusion mediated by Sindbis virus and baculovirus. Human beta-defensin 3 and mannan-binding lectin also blocked viral fusion by creating a protective barricade of immobilized surface proteins. This general mechanism might explain the broad-spectrum antiviral activity of many multivalent lectins of the innate immune system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155572     DOI: 10.1038/ni1248

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  93 in total

1.  Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Authors:  Christophe Paget; Stoyan Ivanov; Josette Fontaine; Joelle Renneson; Fany Blanc; Muriel Pichavant; Laure Dumoutier; Bernhard Ryffel; Jean Christophe Renauld; Philippe Gosset; Pierre Gosset; Mustapha Si-Tahar; Christelle Faveeuw; François Trottein
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

2.  Addition of a C-terminal cysteine improves the anti-herpes simplex virus activity of a peptide containing the human immunodeficiency virus type 1 TAT protein transduction domain.

Authors:  Hermann Bultmann; Jeremy Teuton; Curtis R Brandt
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

Review 3.  The changing of the guard: Molecular diversity and rapid evolution of beta-defensins.

Authors:  Colin A Semple; Phillipe Gautier; Karen Taylor; Julia R Dorin
Journal:  Mol Divers       Date:  2006-11       Impact factor: 2.943

4.  Re: epidemic influenza and vitamin D.

Authors:  John F Aloia; Melissa Li-Ng
Journal:  Epidemiol Infect       Date:  2007-10       Impact factor: 2.451

5.  Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.

Authors:  Wei Wang; Chandrika Mulakala; Sabrina C Ward; Grace Jung; Hai Luong; Duy Pham; Alan J Waring; Yiannis Kaznessis; Wuyuan Lu; Kenneth A Bradley; Robert I Lehrer
Journal:  J Biol Chem       Date:  2006-06-21       Impact factor: 5.157

6.  Stochastic entry of enveloped viruses: fusion versus endocytosis.

Authors:  Tom Chou
Journal:  Biophys J       Date:  2007-05-18       Impact factor: 4.033

7.  Inhibition of herpes simplex virus type 1 infection by cationic beta-peptides.

Authors:  Radeekorn Akkarawongsa; Terra B Potocky; Emily P English; Samuel H Gellman; Curtis R Brandt
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

Review 8.  Host defense peptides in the oral cavity and the lung: similarities and differences.

Authors:  G Diamond; N Beckloff; L K Ryan
Journal:  J Dent Res       Date:  2008-10       Impact factor: 6.116

9.  LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells.

Authors:  David C Brice; Zsolt Toth; Gill Diamond
Journal:  Antiviral Res       Date:  2018-08-02       Impact factor: 5.970

Review 10.  Innate sensors of influenza virus: clues to developing better intranasal vaccines.

Authors:  Takeshi Ichinohe; Akiko Iwasaki; Hideki Hasegawa
Journal:  Expert Rev Vaccines       Date:  2008-11       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.